PMID- 21143965 OWN - NLM STAT- MEDLINE DCOM- 20120126 LR - 20211020 IS - 1466-609X (Electronic) IS - 1364-8535 (Print) IS - 1364-8535 (Linking) VI - 14 IP - 6 DP - 2010 TI - Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats. PG - R223 LID - 10.1186/cc9367 [doi] AB - INTRODUCTION: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), the major endothelial receptor for oxidized low-density lipoprotein, is also involved in leukocyte recruitment. Systemic leukocyte activation in sepsis represents a crucial factor in the impairment of the microcirculation of different tissues, causing multiple organ failure and subsequently death. The aim of our experimental study was to evaluate the effects of LOX-1 inhibition on the endotoxin-induced leukocyte adherence and capillary perfusion within the intestinal microcirculation by using intravital microscopy (IVM). METHODS: We used 40 male Lewis rats for the experiments. Ten placebo-treated animals served as a control. Thirty animals received 5 mg/kg lipopolysaccharide (LPS) intravenously. Ten endotoxemic rats remained untreated. In 10 LPS animals, we administered additionally 10 mg/kg LOX-1 antibodies. Ten further LPS animals received a nonspecific immunoglobulin (rat IgG) intravenously. After 2 hours of observation, intestinal microcirculation was evaluated by using IVM; the plasma levels of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha) were determined; and LOX-1 expression was quantified in intestinal tissue with Western blot and reverse-transcription polymerase chain reaction (PCR). RESULTS: LOX-1 inhibition significantly reduced LPS-induced leukocyte adhesion in intestinal submucosal venules (P < 0.05). At the protein and mRNA levels, LOX-1 expression was significantly increased in untreated LPS animals (P < 0.05), whereas in animals treated with LOX-1 antibody, expression of LOX-1 was reduced (P < 0.05). MCP-1 plasma level was reduced after LOX-1 antibody administration. CONCLUSIONS: Inhibition of LOX-1 reduced leukocyte activation in experimental endotoxemia. LOX-1 represents a novel target for the modulation of the inflammatory response within the microcirculation in sepsis. FAU - Landsberger, Martin AU - Landsberger M AD - Department of Internal Medicine B, University Hospital Greifswald, Friedrich-Loeffler-Strasse 23 a, D-17475 Greifswald, Germany. FAU - Zhou, Juan AU - Zhou J FAU - Wilk, Sebastian AU - Wilk S FAU - Thaumuller, Corinna AU - Thaumuller C FAU - Pavlovic, Dragan AU - Pavlovic D FAU - Otto, Marion AU - Otto M FAU - Whynot, Sara AU - Whynot S FAU - Hung, Orlando AU - Hung O FAU - Murphy, Michael F AU - Murphy MF FAU - Cerny, Vladimir AU - Cerny V FAU - Felix, Stephan B AU - Felix SB FAU - Lehmann, Christian AU - Lehmann C LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101210 PL - England TA - Crit Care JT - Critical care (London, England) JID - 9801902 RN - 0 (Antibodies, Bacterial) RN - 0 (Scavenger Receptors, Class E) SB - IM MH - Animals MH - Antibodies, Bacterial/pharmacology/*therapeutic use MH - Cell Adhesion/immunology MH - Endotoxemia/immunology/*pathology MH - Intestinal Mucosa/*blood supply/immunology/*pathology MH - Leukocytes/*immunology/pathology MH - Male MH - Microcirculation/*immunology MH - Rats MH - Rats, Inbred Lew MH - Scavenger Receptors, Class E/*antagonists & inhibitors/immunology PMC - PMC3220004 EDAT- 2010/12/15 06:00 MHDA- 2012/01/27 06:00 PMCR- 2010/12/10 CRDT- 2010/12/15 06:00 PHST- 2010/04/30 00:00 [received] PHST- 2010/08/03 00:00 [revised] PHST- 2010/12/10 00:00 [accepted] PHST- 2010/12/15 06:00 [entrez] PHST- 2010/12/15 06:00 [pubmed] PHST- 2012/01/27 06:00 [medline] PHST- 2010/12/10 00:00 [pmc-release] AID - cc9367 [pii] AID - 10.1186/cc9367 [doi] PST - ppublish SO - Crit Care. 2010;14(6):R223. doi: 10.1186/cc9367. Epub 2010 Dec 10.